Sultopride

This classification denotes an antipsychotic agent with the molecular formula C17H26N2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AA0G3TW31W, chemically known as o-anisamide, n-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)- but generally known as sultopride, which bears US NIH Compound Identifier 5357. European Medicines Agency schedules Sultopride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10763MIG. The term SULTOPRIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 26, No. 10 1972, List 12). World Health Organization schedules sultopride in its Anatomical Therapeutic Chemical (ATC) Classification. SULTOPRIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule sultopride under HS 29339990 and SITC 51577. As of Q4 2014, SULTOPRIDE remains the US FDA Preferred Term for this commodity. Sultopride bears US NLM identifiers UMLS ID C0075630 and NCI Concept Code C73291. SMILES: S(=O)(=O)(C1CC(C(=O)NCC2N(CCC2)CC)C(OC)CC1)CC.